9 results
8-K
EX-99.2
NPCE
NeuroPace Inc
8 Jan 24
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates
7:05am
for reference purposes only. Such use should not be construed as an endorsement of such products or services. 2
NEUROPACE MISSION Transform the lives
8-K
EX-99.1
NPCE
NeuroPace Inc
8 Aug 23
NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
4:09pm
indication-expanding clinical trial, in the first quarter of 2024. The Company is committed to advancing its mission of transforming the lives of patients
10-K
2021 FY
NPCE
NeuroPace Inc
10 Mar 22
Annual report
5:19pm
strategies will contribute to growth in initial patient implants and advance our mission to dramatically improve clinical outcomes and quality of life … , financial conditions, results of operations and prospects.”
Human Capital Resources
NeuroPace was founded with a mission to transform the lives of people
424B4
NPCE
NeuroPace Inc
23 Apr 21
Prospectus supplement with pricing info
6:02am
implants and advance our mission to dramatically improve clinical outcomes and quality of life for patients suffering from epilepsy and other disabling … our mission to dramatically improve clinical outcomes and quality of life for patients suffering from epilepsy and other disabling brain disorders
POS AM
t2e9i652
21 Apr 21
Prospectus update (post-effective amendment)
6:06am
S-1/A
sujbt7ej8 md3906t
14 Apr 21
IPO registration (amended)
6:09am
S-1
1exsy785 d4biw5tv1
24 Mar 21
IPO registration
5:03pm
DRS
52cr t0g6
29 Jan 21
Draft registration statement
12:00am
- Prev
- 1
- Next